KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Bioverativ Execs Snagged a Nice Payday After Sanofi Deal February 8, 2018 Bristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III July 30, 2017 31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant February 2, 2017
Bristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III July 30, 2017
